Lester in trouble...

The FDA's crumbling reputation continues as former head Lester Crawford (of the refusal to issue a decision on Plan B fame) is being investigated for financial improprieties.

Apparently Crawford held stock in several biotech companies while acting as head commissioner.  The explanation, namely that his decisions weren't influenced simply because he disclosed investments, isn't cutting it for federal investigators. 

I guess the ethics rules regarding NIH researchers and financial investments don't hold for the head of the FDA.  Common sense rules again over at the administration...